Clinical trial of intraoperative radiation and external-beam radiation combined with twice-weekly gemcitabine for the treatment of locally advanced pancreatic cancer

Wada, Michihiko; Hosotani, Ryo; Kajiwara, Tatehiro; Kokubo, Masaki; Senda, Michio
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS63
Academic Journal
An abstract to the article "Clinical Trial of Intraoperative Radiation and External-Beam Radiation Combined With Twice-Weekly Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer," by Michihiko Wada, Ryo Hosotani, Tatehiro Kajiwara, Masaki Kokubo and Michio Senda is presented.


Related Articles

  • Pancreatic cancer incidence. Miller, Barry // JNCI: Journal of the National Cancer Institute;10/19/94, Vol. 86 Issue 20, p1497 

    Reports on the incidence of pancreatic cancer in the United States. Decline in overall incidence from 1973 to 1991.

  • ERRATUM.  // Oncologist;Jun2008, Vol. 13 Issue 6, p738 

    A correction to the article "Metastatic Pancreatic Cancer 2008: Is the Glass Less Empty?" that was published in previous issue is presented.

  • Limited resection of pancreatic cancer in high-risk patients can result in a second primary. Potjer, T. P.; Bartsch, D. K.; Slater, E. P.; Matthäi, E.; Bonsing, B. A.; Vasen, H. F. A. // Gut;Aug2015, Vol. 64 Issue 8, p1342 

    A letter to the editor in response to the article "International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer" that wa published in a 2013 issue of the periodical is presented.

  • Pancreatic Cancer: Pathogenesis, Diagnosis, and Treatment. Benson III, Al B. // Annals of Internal Medicine;02/02/99, Vol. 130 Issue 3, p251 

    Reviews the book `Pancreatic Cancer: Pathogenesis, Diagnosis, and Treatment,' by H.A. Reber.

  • Helicobacter pylori Seropositivity as a Risk Factor for Pancreatic Cancer. Stolzenberg-Solomon, Rachael Z.; Blaser, Martin J.; Limburg, Paul J.; Perez-Perez, Guillermo; Taylor, Phillip R.; Virtamo, Jarmo; Albanes, Demetrius // JNCI: Journal of the National Cancer Institute;6/20/2001, Vol. 93 Issue 12, p937 

    Reports the association of Helicobacter pylori and pancreatic cancer. Levels of immunoglobulin G antibodies to H. pylori; Estimation of the smoking-adjusted odds ratio and confidence intervals; Stimulation of pancreatic growth.

  • The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer. Zogopoulos, George; Rothenmund, Heidi; Eppel, Ayelet; Ash, Colleen; Akbari, Mohammad; Hedley, David; Narod, Steven A.; Gallinger, Steven // Human Genetics;Jul2007, Vol. 121 Issue 6, p767 

    A correction to the article "The P239S Palladin Variant Does not Account for a Significant Fraction of Hereditary or Early Onset Pancreas Cancer" that was published in the May 24, 2007 issue is presented.

  • Familial association of benign pancreatic hyperenzymaemia and pancreatic cancer. L. Gullo; Migliori, M.; Fusaroli, P.; Caletti, G. // Gut;Sep2007, Vol. 56 Issue 9, p1323 

    A letter to the editor is presented in response to the article about the familial association of benign pancreatic hyperenzymaemia (BPH) and pancreatic cancer.

  • Risk of pancreatic cancer in patients with cystic fibrosis. Maisonneuve, P.; Marshall, B. C.; Lowenfels, A. B. // Gut;Sep2007, Vol. 56 Issue 9, p1327 

    A letter to the editor is presented in response to the article about the risk of pancreatic cancer in patients with cystic fibrosis.

  • Low--molecular-weight heparin reduced symptomatic VTE in pancreatic cancer. O'Reilly, Eileen // Hem/Onc Today;7/10/2009, Vol. 10 Issue 13, p18 

    This article focuses on a study which found an association between enoxaparin and a lower incidence of symptomatic venous thromboembolism when used with chemotherapy in patients with advanced pancreatic cancer.

  • Risk of pancreatic adenocarcinoma in chronic pancreatitis. Malka, D.; Hammel, P.; Maire, F.; Rufat, P.; Madeira, I.; Pessione, F.; Lévy, P.; Ruszniewski, P. // Gut;Dec2002, Vol. 51 Issue 6, p849 

    Background: The risk of pancreatic cancer in patients with chronic pancreatitis (CP) is difficult to assess. Previous studies, mostly case control studies or studies relying on data case registers, reported relative risks varying from 2.3 to 18.5. Methods: We studied a prospective, single...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics